Skip to content

Improving Sleep Health and Circadian Timing to Support Cardiometabolic Health in Adolescents

Mitigating Cardiometabolic Risk by Improving Sleep Health and Circadian Timing in Adolescents With Overweight/Obesity

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07618117
Acronym
REST
Enrollment
60
Registered
2026-06-01
Start date
2026-08-25
Completion date
2030-08-30
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Overweight Adolescents, Sleep

Brief summary

Many teenagers get too little and late timed sleep. High body weight and diabetes are increasing in teenagers as well. This study plans to learn more about whether improving sleep habits can help improve how the body regulates blood sugar and energy use in teenagers who have higher body weight. To answer this question, the investigators plan to enroll teenagers who get \<7 hours of sleep on school nights and measure changes in blood sugars and energy use after two weeks of typical sleep (sleeping on their normal school schedule) and two weeks of a sleep intervention that includes spending longer time in bed at night, melatonin, and morning light.

Interventions

BEHAVIORALCircadian/Sleep (C/S)

1h additional time in bed, melatonin 2h before bedtime, and 30 minutes bright light after waking

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

1. High school students between 14-19 years 2. Overweight/obesity (BMI \>85% for age and sex) 3. Have habitually insufficient sleep, defined as ≤ 7 hours per night on school days 4. Habitually inactive (≤ 3 h of physical activity reported per week) 5. Tanner stage 4 or 5, based on breast development for girls and testicular size for boys.

Exclusion criteria

1. Reported diagnosis of sleep disorder (e.g., insomnia, obstructive sleep apnea) 2. Medical comorbidities that impact sleep or insulin sensitivity (e.g., diabetes \[based on history or screening HbA1c\]) 3. Regular use of medications affecting sleep or insulin sensitivity (e.g., stimulants, sleep aids, systemic steroids, insulin sensitizers, GLP-1 agonists) 4. IQ\<70 or severe mental illness that may impact sleep or study participation (e.g., schizophrenia), eating disorder, or active suicidal ideation 5. Schedules that would preclude participants from adhering to the sleep schedules (e.g., night-shift employment)

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivityAssessed at 2 weeks following each conditionMatsuda Index will be calculated from a mixed meal tolerance test (MMTT); higher values indicate better insulin sensitivity.

Secondary

MeasureTime frameDescription
Total daily energy expenditure (TDEE)Assessed for two weeks during each conditionAssessed with doubly labeled water. Higher values indicate greater energy expenditure
Average daily caloric intake (kcal/day)Measured for 3 days during each conditionCalculated from photographic diet diaries. Higher kcal indicates greater caloric intake.

Contacts

CONTACTStacey L Simon, PhD
stacey.simon@childrenscolorado.org720-777-5681
CONTACTAngel Arias, BS
angel.arias@childrenscolorado.org720-777-3491
PRINCIPAL_INVESTIGATORStacey L Simon

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026